Literature DB >> 19428554

Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

Carol A Albright1, R Balfour Sartor, Susan L Tonkonogy.   

Abstract

Interleukin-10 deficient (IL-10-/-) mice develop chronic T cell-mediated colitis when colonized with normal commensal bacteria, but germ-free (GF) IL-10-/- mice remain disease-free. Antigen presenting cells (APC) secrete regulatory cytokines that help determine T lymphocyte activation or tolerance. CD4(+) T cells from the mesenteric lymph nodes of inflamed IL-10-/- mice secrete more IFN-gamma and IL-17 when cultured with cecal bacterial lysate-pulsed splenic APC from IL-10-/- mice than when cultured with normal control APC. GF IL-10-/- APC induce similar IFN-gamma and IL-17 responses; therefore, the functional difference between normal and IL-10 deficient APC is inherent to the lack of IL-10 and not secondary to inflammation. Bacterial lysate-pulsed normal APC cultured with CD4(+) cells from colitic IL-10-/- mice or with exogenous IFN-gamma secrete higher amounts of IL-10 compared to the same APC cultured with naïve T cells. APC enriched for CD11c(+) cells are potent activators of IFN-gamma and IL-17 production by CD4(+) cells from IL-10-/- mice. These APC also produce IL-12/IL-23 p40 and IL-10. Recombinant IL-10 suppressed and anti-IL-10 receptor antibody increased IFN-gamma, IL-17 and IL-12/IL-23 p40 production in bacterial lysate-pulsed APC and plus CD4(+) T cell co-cultures. Taken together, our results show that endogenous IL-10 produced by APC inhibits responses to commensal bacteria and influences the ability of APC to stimulate IFN-gamma-producing effector lymphocytes, which reciprocally, induce IL-10 production by APC. Cytokines produced by APC are an important determinant of pathogenic versus protective mucosal immune responses to colonic bacterial stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428554      PMCID: PMC2680779          DOI: 10.1016/j.imlet.2009.02.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  55 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  Bioactive IL-18 expression is up-regulated in Crohn's disease.

Authors:  G Monteleone; F Trapasso; T Parrello; L Biancone; A Stella; R Iuliano; F Luzza; A Fusco; F Pallone
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

3.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

Review 4.  New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.

Authors:  Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-11-02       Impact factor: 4.962

5.  Anti-interleukin-12 antibody for active Crohn's disease.

Authors:  Peter J Mannon; Ivan J Fuss; Lloyd Mayer; Charles O Elson; William J Sandborn; Daniel Present; Ben Dolin; Nancy Goodman; Catherine Groden; Ronald L Hornung; Martha Quezado; Zhiqiong Yang; Markus F Neurath; Jochen Salfeld; Geertruida M Veldman; Ullrich Schwertschlag; Warren Strober
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

6.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.

Authors:  S Wirtz; S Finotto; S Kanzler; A W Lohse; M Blessing; H A Lehr; P R Galle; M F Neurath
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

8.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor.

Authors:  S D Spencer; F Di Marco; J Hooley; S Pitts-Meek; M Bauer; A M Ryan; B Sordat; V C Gibbs; M Aguet
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

View more
  6 in total

1.  Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.

Authors:  Bo Liu; Susan L Tonkonogy; R Balfour Sartor
Journal:  Gastroenterology       Date:  2011-04-30       Impact factor: 22.682

2.  IL-10 restrains IL-17 to limit lung pathology characteristics following pulmonary infection with Francisella tularensis live vaccine strain.

Authors:  Samantha R Slight; Leticia Monin; Radha Gopal; Lyndsay Avery; Marci Davis; Hillary Cleveland; Tim D Oury; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Pathol       Date:  2013-09-03       Impact factor: 4.307

3.  IL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis.

Authors:  Taku Kobayashi; Katsuyoshi Matsuoka; Shehzad Z Sheikh; Steven M Russo; Yoshiyuki Mishima; Colm Collins; Edwin F deZoeten; Christopher L Karp; Jenny P Y Ting; R Balfour Sartor; Scott E Plevy
Journal:  J Immunol       Date:  2012-07-11       Impact factor: 5.422

4.  Neisseria gonorrhoeae induces a tolerogenic phenotype in macrophages to modulate host immunity.

Authors:  Alejandro Escobar; Enzo Candia; Sebastian Reyes-Cerpa; Bélgica Villegas-Valdes; Tanya Neira; Mercedes Lopez; Kevin Maisey; Fabián Tempio; Miguel Ríos; Claudio Acuña-Castillo; Mónica Imarai
Journal:  Mediators Inflamm       Date:  2013-09-24       Impact factor: 4.711

5.  Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation.

Authors:  Weiyan Zhu; Melissa S Ventevogel; Kayla J Knilans; James E Anderson; Laurel M Oldach; Karen P McKinnon; Marcia M Hobbs; Gregory D Sempowski; Joseph A Duncan
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

6.  Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease.

Authors:  Gabriella Leccese; Alessia Bibi; Stefano Mazza; Federica Facciotti; Flavio Caprioli; Paolo Landini; Moira Paroni
Journal:  Cells       Date:  2020-08-01       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.